Search

Your search keyword '"S Compeyrot-Lacassagne"' showing total 31 results

Search Constraints

Start Over You searched for: Author "S Compeyrot-Lacassagne" Remove constraint Author: "S Compeyrot-Lacassagne"
31 results on '"S Compeyrot-Lacassagne"'

Search Results

1. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

2. OP0221 EFFICACY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)

3. THU0213 Adalimumab in Combination with Methotrexate for The Treatment of Juvenile Idiopathic Arthritis Associated Uveitis: The Sycamore Trial

7. Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland.

8. Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.

9. Collaborative approach to paediatric chronic non-bacterial osteomyelitis of the mandible: Great Ormond Street Hospital case series.

10. Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients.

11. Pediatric uveitis: Role of the pediatrician.

12. Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.

13. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.

15. Inflammatory Arthritis as a Possible Feature of Coffin-Siris Syndrome.

16. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.

17. Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.

18. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.

19. Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis.

20. Infantile-onset LMNA-associated Muscular Dystrophy Mimicking Juvenile Idiopathic Inflammatory Myopathy.

21. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).

22. Effect of biologic treatments on growth in children with juvenile idiopathic arthritis.

23. Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes.

24. Functional status in severe juvenile idiopathic arthritis in the biologic treatment era: an assessment in a French paediatric rheumatology referral centre.

26. The clinical spectrum of 94 patients carrying a single mutated MEFV allele.

28. Inflammatory myopathies in children.

29. Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.

30. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.

31. Inflammatory myopathies in children.

Catalog

Books, media, physical & digital resources